Ferring to Acquire Next-Gen IVF Startup Gameto for up to $1.4B

Austin women's health startup to be acquired for $1.4B

Ferring to acquire next-gen IVF startup Gameto for up to $1.4B

The buyout hands Ferring rights to a technology capable of simplifying the lengthy and burdensome process of in vitro fertilization.

Ferring builds in reproductive health via $1.38bn Gameto buy

Switzerland's Ferring Pharma has reached an agreement to buy US fertility start-up Gameto for up to $1.38bn.

Ferring to buy fertility biotech Gameto for up to $1.38 billion - European Biotechnology Magazine

Swiss pharma group Ferring Pharmaceuticals has agreed to acquire New York-based Gameto for up to $1.3825 billion (€1.24 billion), gaining a cell-based approach designed to shorten the hormone treatment needed for in vitro fertilization (IVF) and egg freezing.

Ferring to acquire ovary-in-a-dish startup Gameto for up to $1.38B

Ferring Pharmaceuticals has signed an agreement to acquire the fertility startup Gameto in a deal that could be worth up to $1.3825 billion, the companies told Endpoints News ahead of a